JP2015525770A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015525770A5 JP2015525770A5 JP2015522168A JP2015522168A JP2015525770A5 JP 2015525770 A5 JP2015525770 A5 JP 2015525770A5 JP 2015522168 A JP2015522168 A JP 2015522168A JP 2015522168 A JP2015522168 A JP 2015522168A JP 2015525770 A5 JP2015525770 A5 JP 2015525770A5
- Authority
- JP
- Japan
- Prior art keywords
- diagnosis
- therapy
- activity inhibitor
- inhibitor
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 101150114527 Nkx2-5 gene Proteins 0.000 claims 1
- 101100460507 Xenopus laevis nkx-2.5 gene Proteins 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Claims (1)
- 治療又は診断に用いるための、Ｎｋｘ２．５活性阻害剤。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1212773.4A GB201212773D0 (en) | 2012-07-18 | 2012-07-18 | Vascular remodelling |
| GB1212773.4 | 2012-07-18 | ||
| PCT/GB2013/051916 WO2014013254A1 (en) | 2012-07-18 | 2013-07-18 | Inhibitors of nkx2.5 for vascular remodelling |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015525770A JP2015525770A (ja) | 2015-09-07 |
| JP2015525770A5 true JP2015525770A5 (ja) | 2016-09-08 |
Family
ID=46799797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015522168A Withdrawn JP2015525770A (ja) | 2012-07-18 | 2013-07-18 | 血管再構築のためのＮｋｘ２．５阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20150190391A1 (ja) |
| EP (1) | EP2874629A1 (ja) |
| JP (1) | JP2015525770A (ja) |
| GB (1) | GB201212773D0 (ja) |
| WO (1) | WO2014013254A1 (ja) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP223198A0 (en) * | 1998-03-06 | 1998-04-02 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| US8258111B2 (en) * | 2008-05-08 | 2012-09-04 | The Johns Hopkins University | Compositions and methods related to miRNA modulation of neovascularization or angiogenesis |
| BR112012007555B1 (pt) * | 2009-10-02 | 2020-09-29 | Cylene Pharmaceuticals, Inc | Métodos in vitro para prever a sensibilidade e resposta de doenças mediadas por proteína quinase ck2 a inibidores de ck2 |
-
2012
- 2012-07-18 GB GBGB1212773.4A patent/GB201212773D0/en not_active Ceased
-
2013
- 2013-07-18 EP EP13740346.5A patent/EP2874629A1/en not_active Withdrawn
- 2013-07-18 WO PCT/GB2013/051916 patent/WO2014013254A1/en active Application Filing
- 2013-07-18 JP JP2015522168A patent/JP2015525770A/ja not_active Withdrawn
- 2013-07-18 US US14/415,558 patent/US20150190391A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015503422A5 (ja) | ||
| HK1216251A1 (zh) | 吡唑並吡咯烷衍生物及其治病作用 | |
| JP2014530840A5 (ja) | ||
| JP2013188229A5 (ja) | ||
| JP2013525942A5 (ja) | ||
| DK3065764T6 (da) | Mini-gastrin-analog, især til anvendelse i CCK-2-receptor-positive tumordiagnoser og/eller -behandling | |
| BR302013006822S1 (pt) | Configuração aplicada em curativo médico. | |
| PL3004112T3 (pl) | Pochodne pirazolo-pirolidyn-4-onu oraz ich zastosowanie w leczeniu choroby | |
| JP2013231052A5 (ja) | ||
| JP2015173751A5 (ja) | ||
| EP2976091C0 (de) | Antioxidativ wirksame zusammensetzung und deren verwendung | |
| DK2816947T3 (da) | Endoskopisk anordning, særlig til medicinsk brug | |
| JP2015016294A5 (ja) | ||
| JP2011170857A5 (ja) | ||
| JP2014529579A5 (ja) | ||
| JP2011181497A5 (ja) | ||
| HK1214511A1 (zh) | 鹽酸蘭地洛爾在快速性心律失常的長期治療中的用途 | |
| JP2017516883A5 (ja) | ||
| JP2015525770A5 (ja) | ||
| IL244576A0 (en) | Anti-vstm5 antibodies and their use for treatment and diagnosis | |
| GB201408668D0 (en) | The use of tetranectin in the diagnosis and management of cardiovascular diseases | |
| TH1401006421A (th) | สารประกอบสำหรับการใช้ในการผลิตยาสำหรับการรักษาโรคผิวหนังที่ตอบสนองต่อสเตียรอยด์ | |
| JP2015071467A5 (ja) | ||
| AP2015008849A0 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| TH1501007642A (th) | ยาใช้ภายนอกสำหรับผิวหนัง |